NEW

GE HealthCare Preps for SIR 2024

GE HealthCare will showcase its latest technologies in image guiding solutions, surgery, ultrasound and CT-navigation at the upcoming 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting taking place March 23-28 in Salt Lake City, Utah. The...

Samsung Accepts Healthcare Innovator Award

Boston Imaging, the United States headquarters of Samsung’s digital radiography and ultrasound business, was awarded HHM Health’s Healthcare Innovator Award

AHRA Co-Founder Passes Away

On March 2, 2024, Louise Broadley passed away at 101 years old. AHRA shared the news via an email and website post that reads, “She was a noble woman, who not only achieved many milestones within the imaging profession, but likewise paved the way for aspiring leaders...

Artificial Intelligence Paper Outlines FDA’s Approach to Protect Public Health and Promote Ethical Innovation

Today, the U.S. Food and Drug Administration (FDA) released its “Artificial Intelligence and Medical Products: How CBER, CDER, CDRH, and OCP are Working Together,” which outlines how FDA’s medical product centers are working together to protect public health while...

FDA Issues Final Guidance on Medical Devices in the MR Environment

FDA

Today, the U.S. Food and Drug Administration (FDA) issued this final guidance: Testing and Labeling Medical Devices for Safety in the Magnetic Resonance (MR) Environment. This guidance document provides the FDA’s recommendations on testing to assess the safety and compatibility of medical devices in the MR Environment and the recommended format for Magnetic Resonance Imaging (MRI) Safety Information in medical device labeling. Ensuring the safety of patients who use magnetic resonance imaging (MRI) for disease diagnosis and health management is vital.

Read the Guidance »

Facts about the final guidance

This final guidance:

  • Provides recommended format to clarify and simplify labeling for magnetic resonance imaging (MRI) safety information consistent with FDA-recognized consensus standards.
  • Applies to all medical devices that might be used in the MR environment, including all implanted medical devices and all medical devices that are fastened to or carried by a patient (such as, external insulin pump or pulse oximeter). Note: the guidance does not apply to the MR system or accessories, such as MR coils and positioning pads.
  • Provides recommendations on MR safety and compatibility assessments and labeling information that should be included in premarket submissions.

Upcoming webinar on this guidance

On June 24, 2021, the FDA will host a webinar for industry and others interested in learning more about the guidance.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

Open